Tech Company Financing Transactions
Diagenode Funding Round
Capricorn Healthcare and private investors participated in a $8.5 million funding round for Diagenode. This VC investment round was announced on 6/21/2016.
Transaction Overview
Company Name
Announced On
6/21/2016
Transaction Type
Venture Equity
Amount
$8,499,000
Round
Undisclosed
Investors
Proceeds Purpose
With the additional funding, we can fuel growth of new technologies in both epigenetics and diagnostics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Morris Ave. 101
Denville, NJ 07834
USA
Denville, NJ 07834
USA
Phone
Website
Email Address
Overview
Diagenode is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays based in Liège, Belgium and Denville, NJ, USA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Didier Allaer
Browse more venture capital transactions:
Prev: 6/21/2016: Piper venture capital transaction
Next: 6/21/2016: Bonfyre venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs